Sexual side effects of a lung cancer diagnosis can be physical, mental, and emotional. Sexuality is about emotional connection and the expression of intimacy. However, a lung cancer diagnosis can change the emotional needs of each partner. Further impacting the situation, sexual problems are not often discussed during oncology visits. And having a sex talk with your doctor may be intimidating. In this podcast, we undercover what lung cancer patients and their partners can expect and how to best discuss these issues with their health care professionals.  Questions like: How does a ..read more

This episode of Hope With Answers: Living with Lung Cancer Podcast tackles the common misperception that all cancer patients fit the stereotype of being older, frail, chain-smokers. 60% of people living with lung cancer are never-smokers – who work hard to convince others, including their primary care physician, that despite their rather “normal”, vibrant appearance, they face a devastating disease. Host Diane Mulligan opens the episode by asking “What does someone living with lung cancer look like?” She and co-host Jordan Sherman go on to make the point that in reality, anyone with lungs c ..read more

Immunotherapy has revolutionized the therapy landscape of non-small cell lung cancer, significantly prolonging the overall survival of advanced-stage patients. We hear from both doctors and patients about the importance of Immunotherapy research. Dr. Smith will discuss her research advancements, thanks to LCFA funding, and what needs to be done for research in the future. In this inspiring Hope With Answers: Living With Lung Cancer episode, host Diane Mulligan sits down with Lysa Buonanno, a remarkable individual who has defied the odds and thrived while living with lung cancer. Lysa’s story ..read more

Every donation made to LCFA impacts people living with lung cancer. In other words, the benefits that you, as an LCFA donor, have made in lung cancer research and education by supporting LCFA are significant and meaningful. Hear from Dr. Triparna Sen, a dedicated researcher in the field of lung cancer who demonstrates LCFA’s commitment to advancing the understanding and treatment of lung cancer. According to Dr. Sen, “With the progress of research, we are seeing a lot of more effective drugs entering the clinic. We have some really long-term survivors. We have five years, 10 years out surviv ..read more

Doctors and researchers have known about a biomarker known as MTAP deletion for many years. But now they’re learning what role this gene plays in lung cancer and other tumors. Long ago, this genetic alteration was thought to be just collateral damage in tumors, but now researchers are uncovering its influence on tumors. It turns out there are some advantages for a tumor to have this MTAP gene loss. This new understanding means new medications can likely be developed to open a new weak point in the cancer to allow for targeted therapy. Guest Jordi Rodon Ahnert, MD, PhD, medical oncologist ..read more

El cáncer de pulmón de células pequeñas (CPCP) es una forma rara y agresiva de cáncer de pulmón. Los tratamientos tradicionales son una combinación de quimioterapia y radiación. Pero, gracias a los avances en la investigación del cáncer de pulmón, nuevas posibilidades de tratamiento están disponibles. Estos nuevos tratamientos están diseñados para prolongar la vida y ayudar a los pacientes a tener una mejor calidad de vida. Como dice Mari Casanova, paciente de CPCP: “No te puedo decir cuánto tiempo voy a durar, pero lo que si te puedo decir es cuánto tiempo he estado sana. Y han pasado tres ..read more

Los navegadores de pacientes pueden ayudar a entender sus opciones de tratamiento para el cáncer de pulmón Un navegador de pacientes ayuda a los pacientes a entender sus opciones de tratamiento para el cáncer de pulmón y la importancia de las últimas investigaciones y ensayos clínicos. Esto incluye asistir al paciente a través de la detección, el diagnóstico, el tratamiento y el seguimiento del cáncer de pulmón. INVITADOS Estelamari Rodríguez, co-directora de oncología médica torácica en el Sylvester Comprehensive Cancer Center de la Universidad de Miami Grisel Fernández-Vega Martínez, enferm ..read more

In Part 2 of this Hope With Answers series on CBD, Cannabis, and Lung Cancer, we discuss the differences between CBD oil and hemp oil and what’s happening on the CBD clinical trials horizon. Once again, Jacquelyn Bainbridge, a clinical pharmacist at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus, joins us to talk about her clinical research, including work on cannabis clinical trials with hopes that CBD could help lung cancer patients. “CBD potentially, or has a potential, to alter the immune environment and stimulate a respons ..read more

There is so much hope in lung cancer today. But lung cancer is also inherently very complicated. And the process of getting to a treatment plan takes a lot of expertise, different members of a medical team and lots of tests. And one way to make this process easier on patients and more efficient for doctors who are making those treatment plans is to use an expert called a patient or nurse navigator. Guests Charity Holien, RN, a nurse navigator with the University of Colorado Cancer Center Ross Camidge, MD, PhD, Director of the Thoracic Oncology Clinical and Clinical Research Programs at U ..read more

Of all the emotions that come with a lung cancer diagnosis, a sense of being alone might be the toughest. How can you connect with people who understand exactly what you’re going through? Hear from two people living with EGFR lung cancer who are creating connections among others with the same biomarker. Learn how sharing experiences, information, and understanding, is creating hope with answers for those in the EGFR biomarker community – while advocating for more lung cancer research. Guests: Jill Feldman, lung cancer patient/advocate, follow her on Twitter @jillfeldman4 Ivy Elkins, lung can ..read more